主动脉瓣狭窄、心力衰竭与主动脉瓣置换术
本综述探讨主动脉瓣狭窄(AS)与心力衰竭(HF)的相互作用,分析AS所致心肌改变、主动脉瓣置换术(AVR)对这些改变的影响及AVR前后HF的患病率与相关因素。综述指出AVR前后HF患病率均高,尤其左室功能不全者;AS增加后负荷引起心脏重构,初期良性但逐渐适应不良,促进HF和死亡;HF进展受反向重构程度、合并症、瓣膜假体血流动力学及血管僵硬度影响;多种血液和影像生物标志物可预测死亡和HF。
要点
- AS与HF常共存,AVR前后HF患病率均高,尤其左室功能不全者。
- AS后负荷增加引起心脏重构,初期良性但逐渐适应不良,促进HF和死亡。
- 反向心脏重构程度、合并症、瓣膜假体血流动力学和血管僵硬度影响HF进展。
核心结论
- AS中HF发生是多因素的,其与左室功能不全的联系是复杂过程。
- 明确AS中HF入院决定因素对识别高危个体至关重要。
- 用替代标志物识别左室失代偿早期迹象可能是关键,甚至在左室功能受损之前。
- 将多模态影像技术和生物标志物转化为常规临床实践,并与影响AVR前后HF的患者和手术因素整合,可促进及时干预。
研究设计与样本
- 综述,旨在全面分析AS与HF的相互作用。
主要发现
- AVR前后HF患病率均高,尤其左室功能不全患者。
- AS增加后负荷引起心脏重构,初期良性但随时间变为适应不良,促进HF和死亡率增加。
- HF进展受反向心脏重构程度影响,可受合并症、瓣膜假体血流动力学性能和血管僵硬度影响。
- 多种血液和影像生物标志物可提供AS病理生理见解,作为死亡率预测因子并预测HF。
临床怎么用
- 使用替代标志物识别左室失代偿早期迹象,甚至在左室功能受损之前。
- 将多模态影像技术和生物标志物转化为常规临床实践以评估心脏损伤。
- 将标志物与影响AVR前后HF的患者和手术因素整合,促进及时干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Heart failure (HF) and aortic stenosis (AS) frequently coexist, presenting a complex clinical challenge due to their intertwined pathophysiology and associated high morbidity and mortality. Despite numerous advancements in transcatheter and surgical aortic valve replacement (AVR), HF decompensation remains the leading cause of cardiac rehospitalization and a major predictor of mortality in patients with AS, before or after AVR. This review aims to provide a comprehensive analysis of the interplay between AS and HF, delving into myocardial changes caused by stenotic insult, the impact of AVR on these changes, and the prevalence and contributing elements of HF before and after AVR. OBSERVATIONS: The prevalence of HF remains high before and after AVR, particularly among patients with left ventricular dysfunction. Increased afterload from AS causes cardiac remodeling, which is initially benign but over time these changes become maladaptive, contributing to HF and increased mortality. The progression of HF is influenced by the degree of reverse cardiac remodeling, which can be affected by comorbid conditions, the hemodynamic performance of the valve prosthesis, and vascular stiffness. Several blood and imaging biomarkers offer insights into underlying AS pathophysiology, serving as mortality predictors and predicting HF in this patient population. CONCLUSIONS AND RELEVANCE: HF development in AS is multifactorial and its link to left ventricular dysfunction is a complex process. Delineating the determinants of HF admissions in AS is crucial for identifying individuals at high risk. Identifying the early signs of left ventricular decompensation by using surrogate markers may be the key, even before left ventricular function becomes impaired. Translating multimodality imaging techniques and biomarkers into routine clinical practice for evaluating cardiac damage and integrating these markers with patient and procedural factors that affect HF before and after AVR can facilitate timely intervention, minimizing the likelihood of HF progression and influencing future guidelines.
引用
- Mengi, Januzzi, Cavalcante, et al. Aortic Stenosis, Heart Failure, and Aortic Valve Replacement. JAMA Cardiol. 2024. PMID: 39412797. doi:10.1001/jamacardio.2024.3486
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。